ADRX: Chimovits Erez discloses securities transactions

By AlphaYouPublished Sep 30, 2026Form 4

Stocks in this disclosure

Reported activity

Chimovits Erez

Reporting filer

Chimovits Erez reported Conversion in ADARx Pharmaceuticals, Inc.: 7127019 units of Common Stock, dated 2026-09-28. The full Form 4 contains 9 transaction entries.

Disclosed: Sep 30, 2026

Reported details

9 entries

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Chimovits Erez	2026-09-28	C	Conversion	7127019	Not stated (see footnotes)	7,127,019	2 days	Filed terms security Title: Common Stock transaction Date: 2026-09-28 deemed Execution Date: transaction Form Type: 4 transaction Code: C equity Swap Involved: 0 transaction Timeliness: transaction Shares: 7127019 id: F1 transaction Acquired Disposed Code: A shares Owned Following Transaction: 7127019 direct Or Indirect Ownership: I nature Of Ownership: See footnotes id: F3 id: F4
Common Stock	Chimovits Erez	2026-09-28	C	Conversion	1333975	Not stated (see footnotes)	8,460,994	2 days	Filed terms security Title: Common Stock transaction Date: 2026-09-28 deemed Execution Date: transaction Form Type: 4 transaction Code: C equity Swap Involved: 0 transaction Timeliness: transaction Shares: 1333975 id: F1 transaction Acquired Disposed Code: A shares Owned Following Transaction: 8460994 direct Or Indirect Ownership: I nature Of Ownership: See footnotes id: F3 id: F4
Common Stock	Chimovits Erez	2026-09-28	C	Conversion	513067	Not stated (see footnotes)	8,974,061	2 days	Filed terms security Title: Common Stock transaction Date: 2026-09-28 deemed Execution Date: transaction Form Type: 4 transaction Code: C equity Swap Involved: 0 transaction Timeliness: transaction Shares: 513067 id: F1 transaction Acquired Disposed Code: A shares Owned Following Transaction: 8974061 direct Or Indirect Ownership: I nature Of Ownership: See footnotes id: F3 id: F4
Common Stock	Chimovits Erez	2026-09-28	C	Conversion	256448	Not stated (see footnotes)	9,230,509	2 days	Filed terms security Title: Common Stock transaction Date: 2026-09-28 deemed Execution Date: transaction Form Type: 4 transaction Code: C equity Swap Involved: 0 transaction Timeliness: transaction Shares: 256448 id: F1 transaction Acquired Disposed Code: A shares Owned Following Transaction: 9230509 direct Or Indirect Ownership: I nature Of Ownership: See footnotes id: F3 id: F4
Common Stock	Chimovits Erez	2026-09-28	P	Purchase	61516	17.00	9,292,025	2 days	Filed terms security Title: Common Stock transaction Date: 2026-09-28 deemed Execution Date: transaction Form Type: 4 transaction Code: P equity Swap Involved: 0 transaction Timeliness: transaction Shares: 61516 id: F2 transaction Price Per Share: 17.00 transaction Acquired Disposed Code: A shares Owned Following Transaction: 9292025 direct Or Indirect Ownership: I nature Of Ownership: See footnotes id: F3 id: F4
Series A Preferred Stock (derivative)	Chimovits Erez	2026-09-28	C	Conversion	7127019	0	0	2 days	Filed terms security Title: Series A Preferred Stock id: F1 transaction Date: 2026-09-28 deemed Execution Date: transaction Form Type: 4 transaction Code: C equity Swap Involved: 0 transaction Timeliness: transaction Shares: 7127019 transaction Price Per Share: 0 transaction Acquired Disposed Code: D id: F1 id: F1 underlying Security Title: Common Stock underlying Security Shares: 7127019 shares Owned Following Transaction: 0 direct Or Indirect Ownership: I nature Of Ownership: See footnotes id: F3 id: F4
Series B Preferred Stock (derivative)	Chimovits Erez	2026-09-28	C	Conversion	1333975	0	0	2 days	Filed terms security Title: Series B Preferred Stock id: F1 transaction Date: 2026-09-28 deemed Execution Date: transaction Form Type: 4 transaction Code: C equity Swap Involved: 0 transaction Timeliness: transaction Shares: 1333975 transaction Price Per Share: 0 transaction Acquired Disposed Code: D id: F1 id: F1 underlying Security Title: Common Stock underlying Security Shares: 1333975 shares Owned Following Transaction: 0 direct Or Indirect Ownership: I nature Of Ownership: See footnotes id: F3 id: F4
Series B-1 Preferred Stock (derivative)	Chimovits Erez	2026-09-28	C	Conversion	513067	0	0	2 days	Filed terms security Title: Series B-1 Preferred Stock id: F1 transaction Date: 2026-09-28 deemed Execution Date: transaction Form Type: 4 transaction Code: C equity Swap Involved: 0 transaction Timeliness: transaction Shares: 513067 transaction Price Per Share: 0 transaction Acquired Disposed Code: D id: F1 id: F1 underlying Security Title: Common Stock underlying Security Shares: 513067 shares Owned Following Transaction: 0 direct Or Indirect Ownership: I nature Of Ownership: See footnotes id: F3 id: F4
Series C Preferred Stock (derivative)	Chimovits Erez	2026-09-28	C	Conversion	256448	0	0	2 days	Filed terms security Title: Series C Preferred Stock id: F1 transaction Date: 2026-09-28 deemed Execution Date: transaction Form Type: 4 transaction Code: C equity Swap Involved: 0 transaction Timeliness: transaction Shares: 256448 transaction Price Per Share: 0 transaction Acquired Disposed Code: D id: F1 id: F1 underlying Security Title: Common Stock underlying Security Shares: 256448 shares Owned Following Transaction: 0 direct Or Indirect Ownership: I nature Of Ownership: See footnotes id: F3 id: F4

Common Stock

Owner: Chimovits Erez
Date: 2026-09-28
Code: C
Action: Conversion
Quantity: 7127019
Price: Not stated (see footnotes)
Following holdings: 7,127,019
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 7127019
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 7127019
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Common Stock

Owner: Chimovits Erez
Date: 2026-09-28
Code: C
Action: Conversion
Quantity: 1333975
Price: Not stated (see footnotes)
Following holdings: 8,460,994
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 1333975
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 8460994
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Common Stock

Owner: Chimovits Erez
Date: 2026-09-28
Code: C
Action: Conversion
Quantity: 513067
Price: Not stated (see footnotes)
Following holdings: 8,974,061
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 513067
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 8974061
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Common Stock

Owner: Chimovits Erez
Date: 2026-09-28
Code: C
Action: Conversion
Quantity: 256448
Price: Not stated (see footnotes)
Following holdings: 9,230,509
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 256448
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 9230509
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Common Stock

Owner: Chimovits Erez
Date: 2026-09-28
Code: P
Action: Purchase
Quantity: 61516
Price: 17.00
Following holdings: 9,292,025
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: P
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 61516
id: F2
transaction Price Per Share: 17.00
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 9292025
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Series A Preferred Stock (derivative)

Owner: Chimovits Erez
Date: 2026-09-28
Code: C
Action: Conversion
Quantity: 7127019
Price: 0
Following holdings: 0
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Series A Preferred Stock
id: F1
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 7127019
transaction Price Per Share: 0
transaction Acquired Disposed Code: D
id: F1
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 7127019
shares Owned Following Transaction: 0
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Series B Preferred Stock (derivative)

Owner: Chimovits Erez
Date: 2026-09-28
Code: C
Action: Conversion
Quantity: 1333975
Price: 0
Following holdings: 0
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Series B Preferred Stock
id: F1
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 1333975
transaction Price Per Share: 0
transaction Acquired Disposed Code: D
id: F1
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 1333975
shares Owned Following Transaction: 0
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Series B-1 Preferred Stock (derivative)

Owner: Chimovits Erez
Date: 2026-09-28
Code: C
Action: Conversion
Quantity: 513067
Price: 0
Following holdings: 0
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Series B-1 Preferred Stock
id: F1
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 513067
transaction Price Per Share: 0
transaction Acquired Disposed Code: D
id: F1
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 513067
shares Owned Following Transaction: 0
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Series C Preferred Stock (derivative)

Owner: Chimovits Erez
Date: 2026-09-28
Code: C
Action: Conversion
Quantity: 256448
Price: 0
Following holdings: 0
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Series C Preferred Stock
id: F1
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 256448
transaction Price Per Share: 0
transaction Acquired Disposed Code: D
id: F1
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 256448
shares Owned Following Transaction: 0
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Chimovits Erez: Director.
F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series B-1 Preferred Stock, and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted on a 1-for-1.1717 basis into shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock has no expiration date.
F2: Reflects shares of the Issuer's Common Stock purchased in the Issuer's initial public offering.
F3: These securities are held directly by OrbiMed Israel Partners II, L.P. ("OIP II"). OrbiMed Israel GP II, L.P. ("Israel GP") is the general partner of OIP II. OrbiMed Advisors Israel II Limited ("Advisors Israel") is the general partner of Israel GP. By virtue of such relationships, Israel GP and Advisors Israel may be deemed to have voting power and investment power over the securities held by OIP II and as a result, may be deemed to have beneficial ownership over such securities. Advisors Israel exercises this investment and voting power through a management committee comprised of Carl L. Gordon, David P. Bonita, and the Reporting Person, each of whom disclaims beneficial ownership of the shares held by OIP II.
F4: Each of the Reporting Person, Israel GP, and Advisors Israel disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any of such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Common Stock

Chimovits Erez

2026-09-28

Conversion

7127019

Not stated (see footnotes)

7,127,019

2 days

Filed terms

security Title: Common Stock
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 7127019
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 7127019
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Common Stock

Chimovits Erez

2026-09-28

Conversion

1333975

Not stated (see footnotes)

8,460,994

2 days

Filed terms

security Title: Common Stock
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 1333975
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 8460994
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Common Stock

Chimovits Erez

2026-09-28

Conversion

513067

Not stated (see footnotes)

8,974,061

2 days

Filed terms

security Title: Common Stock
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 513067
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 8974061
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Common Stock

Chimovits Erez

2026-09-28

Conversion

256448

Not stated (see footnotes)

9,230,509

2 days

Filed terms

security Title: Common Stock
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 256448
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 9230509
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Common Stock

Chimovits Erez

2026-09-28

Purchase

61516

17.00

9,292,025

2 days

Filed terms

security Title: Common Stock
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: P
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 61516
id: F2
transaction Price Per Share: 17.00
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 9292025
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Series A Preferred Stock (derivative)

Chimovits Erez

2026-09-28

Conversion

7127019

2 days

Filed terms

security Title: Series A Preferred Stock
id: F1
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 7127019
transaction Price Per Share: 0
transaction Acquired Disposed Code: D
id: F1
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 7127019
shares Owned Following Transaction: 0
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Series B Preferred Stock (derivative)

Chimovits Erez

2026-09-28

Conversion

1333975

2 days

Filed terms

security Title: Series B Preferred Stock
id: F1
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 1333975
transaction Price Per Share: 0
transaction Acquired Disposed Code: D
id: F1
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 1333975
shares Owned Following Transaction: 0
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Series B-1 Preferred Stock (derivative)

Chimovits Erez

2026-09-28

Conversion

513067

2 days

Filed terms

security Title: Series B-1 Preferred Stock
id: F1
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 513067
transaction Price Per Share: 0
transaction Acquired Disposed Code: D
id: F1
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 513067
shares Owned Following Transaction: 0
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Series C Preferred Stock (derivative)

Chimovits Erez

2026-09-28

Conversion

256448

2 days

Filed terms

security Title: Series C Preferred Stock
id: F1
transaction Date: 2026-09-28
deemed Execution Date:
transaction Form Type: 4
transaction Code: C
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 256448
transaction Price Per Share: 0
transaction Acquired Disposed Code: D
id: F1
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 256448
shares Owned Following Transaction: 0
direct Or Indirect Ownership: I
nature Of Ownership: See footnotes
id: F3
id: F4

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Chimovits Erez: Director.

F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series B-1 Preferred Stock, and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted on a 1-for-1.1717 basis into shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock has no expiration date.

F2: Reflects shares of the Issuer's Common Stock purchased in the Issuer's initial public offering.

F3: These securities are held directly by OrbiMed Israel Partners II, L.P. ("OIP II"). OrbiMed Israel GP II, L.P. ("Israel GP") is the general partner of OIP II. OrbiMed Advisors Israel II Limited ("Advisors Israel") is the general partner of Israel GP. By virtue of such relationships, Israel GP and Advisors Israel may be deemed to have voting power and investment power over the securities held by OIP II and as a result, may be deemed to have beneficial ownership over such securities. Advisors Israel exercises this investment and voting power through a management committee comprised of Carl L. Gordon, David P. Bonita, and the Reporting Person, each of whom disclaims beneficial ownership of the shares held by OIP II.

F4: Each of the Reporting Person, Israel GP, and Advisors Israel disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any of such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.